Home Tags Neurology
Elon Musk finally took the wraps off his new brain microchip company that plans to connect people’s brains to the internet by next year
Elon Musk's secretive brain microchip company held an event on Tuesday night detailing the work it's been doing. Here's everything we learned!
A dog with ‘fainting goat syndrome’ freezes and falls down when he gets excited, and nobody can figure out why
Peter the cocker spaniel has a neurological condition, similar to that of Mytonic goats, where he occasionally becomes temporarily paralysed.
Ditch your open office, drink coffee strategically, and put your smartphone away to trick your brain into getting more done.
A drug derived from marijuana just got a big lift that will likely make it the first of its kind to get federal approval
A drug derived from marijuana to treat epilepsy is on the brink of winning US government approval. In its third large clinical trial, Epidiolex appeared to significantly reduce the worst symptoms of two severe forms of childhood epilepsy.
The CEO of a biotech founded by a 32-year old is stepping down after 10 months — and the stock is crashing
Axovant CEO David Hung and the company's chief operating officer both left to pursue other opportunities after the company's lead Alzheimer's drug failed.
Brain injuries can cause some people to become violent criminals and pedophiles — here’s what scientists know so far about why that is
Between 50 and 70% of the British prison population have had a brain injury, according to research.
BI PRIME: Neuroscience is having a Renaissance as far as developing new treatments for challenging diseases including Alzheimer's disease and depression.
The death rate from Alzheimer’s disease increased 55% over 15 years — and it points to an important problem
The death rate has big implications on the paid and unpaid caregivers who take care of those living with Alzheimer's from home.
According to a report from the Alzheimer's Association, in 2017, the amount spent on caring for people with Alzheimer's is expected to reach $259 billion.
Takeda Pharmaceuticals is teaming up with New York-based Ovid Therapeutics to co-develop TAK-935, a drug meant to treat rare epilepsy disorders in children.